5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide

C82H79F3N18O8 — CID 160947080

IUPAC5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide
SMILESCOc1cncc(-n2cc(-c3cc(C(=O)NC4CC4)ccc3C)cn2)n1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cncc(C(=O)O)c2)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cncc(C(F)(F)F)c2)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cncc(C3CCOCC3)n2)c1
InChIInChI=1S/C23H25N5O2.C20H17F3N4O.C20H18N4O3.C19H19N5O2/c1-15-2-3-17(23(29)26-19-4-5-19)10-20(15)18-11-25-28(14-18)22-13-24-12-21(27-22)16-6-8-30-9-7-16;1-12-2-3-13(19(28)26-16-4-5-16)6-18(12)14-8-25-27(11-14)17-7-15(9-24-10-17)20(21,22)23;1-12-2-3-13(19(25)23-16-4-5-16)7-18(12)15-9-22-24(11-15)17-6-14(20(26)27)8-21-10-17;1-12-3-4-13(19(25)22-15-5-6-15)7-16(12)14-8-21-24(11-14)17-9-20-10-18(23-17)26-2/h2-3,10-14,16,19H,4-9H2,1H3,(H,26,29);2-3,6-11,16H,4-5H2,1H3,(H,26,28);2-3,6-11,16H,4-5H2,1H3,(H,23,25)(H,26,27);3-4,7-11,15H,5-6H2,1-2H3,(H,22,25)
InChIKeySVGLKULEBIUIFJ-UHFFFAOYSA-N
MW1501.65 g/mol
LogP12.95
Rot. Bonds19

About 5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide

5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide (PubChem CID 160947080) has the molecular formula C82H79F3N18O8 and a molecular weight of 1501.65 g/mol. Its IUPAC name is 5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide.

Molecular Properties

Compound Name5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide
PubChem CID160947080
Molecular FormulaC82H79F3N18O8
Molecular Weight1501.65 g/mol
Exact Mass1500.63
IUPAC Name5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide
SMILESCOc1cncc(-n2cc(-c3cc(C(=O)NC4CC4)ccc3C)cn2)n1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cncc(C(=O)O)c2)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cncc(C(F)(F)F)c2)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cncc(C3CCOCC3)n2)c1
InChIInChI=1S/C23H25N5O2.C20H17F3N4O.C20H18N4O3.C19H19N5O2/c1-15-2-3-17(23(29)26-19-4-5-19)10-20(15)18-11-25-28(14-18)22-13-24-12-21(27-22)16-6-8-30-9-7-16;1-12-2-3-13(19(28)26-16-4-5-16)6-18(12)14-8-25-27(11-14)17-7-15(9-24-10-17)20(21,22)23;1-12-2-3-13(19(25)23-16-4-5-16)7-18(12)15-9-22-24(11-15)17-6-14(20(26)27)8-21-10-17;1-12-3-4-13(19(25)22-15-5-6-15)7-16(12)14-8-21-24(11-14)17-9-20-10-18(23-17)26-2/h2-3,10-14,16,19H,4-9H2,1H3,(H,26,29);2-3,6-11,16H,4-5H2,1H3,(H,26,28);2-3,6-11,16H,4-5H2,1H3,(H,23,25)(H,26,27);3-4,7-11,15H,5-6H2,1-2H3,(H,22,25)
InChIKeySVGLKULEBIUIFJ-UHFFFAOYSA-N
XLogP12.95
TPSA320.78 Ų
H-Bond Donors5
H-Bond Acceptors21
Rotatable Bonds19
Heavy Atoms111
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001501.65
LogP ≤ 512.95
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1021

Analyze 5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide?
The IUPAC name of 5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide (CID 160947080) is 5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide.
What is the SMILES notation for 5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide?
The canonical SMILES for 5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide is COc1cncc(-n2cc(-c3cc(C(=O)NC4CC4)ccc3C)cn2)n1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cncc(C(=O)O)c2)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cncc(C(F)(F)F)c2)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cncc(C3CCOCC3)n2)c1.
What is the InChIKey of 5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide?
The InChIKey is SVGLKULEBIUIFJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H25N5O2.C20H17F3N4O.C20H18N4O3.C19H19N5O2/c1-15-2-3-17(23(29)26-19-4-5-19)10-20(15)18-11-25-28(14-18)22-13-24-12-21(27-22)16-6-8-30-9-7-16;1-12-2-3-13(19(28)26-16-4-5-16)6-18(12)14-8-25-27(11-14)17-7-15(9-24-10-17)20(21,22)23;1-12-2-3-13(19(25)23-16-4-5-16)7-18(12)15-9-22-24(11-15)17-6-14(20(26)27)8-21-10-17;1-12-3-4-13(19(25)22-15-5-6-15)7-16(12)14-8-21-24(11-14)17-9-20-10-18(23-17)26-2/h2-3,10-14,16,19H,4-9H2,1H3,(H,26,29);2-3,6-11,16H,4-5H2,1H3,(H,26,28);2-3,6-11,16H,4-5H2,1H3,(H,23,25)(H,26,27);3-4,7-11,15H,5-6H2,1-2H3,(H,22,25).
What are the key properties of 5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide?
5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide has a molecular weight of 1501.65 g/mol, XLogP of 12.95, 19 rotatable bonds, 5 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]pyridine-3-carboxylic acid;N-cyclopropyl-3-[1-(6-methoxypyrazin-2-yl)pyrazol-4-yl]-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-[6-(oxan-4-yl)pyrazin-2-yl]pyrazol-4-yl]benzamide;N-cyclopropyl-4-methyl-3-[1-[5-(trifluoromethyl)-3-pyridinyl]pyrazol-4-yl]benzamide is sourced from PubChem (CID 160947080), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).